Detalhe da pesquisa
1.
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study).
Ann Rheum Dis
; 83(4): 421-428, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071508
2.
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries.
Rheumatology (Oxford)
; 63(3): 751-764, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37314967
3.
Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?
J Rheumatol
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38621792
4.
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries.
Ann Rheum Dis
; 82(6): 820-828, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36813538
5.
After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries.
Ann Rheum Dis
; 82(2): 175-181, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36100351
6.
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Ann Rheum Dis
; 82(10): 1286-1295, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423647
7.
IL-17A and TNF synergistically drive expression of proinflammatory mediators in synovial fibroblasts via IκBζ-dependent induction of ELF3.
Rheumatology (Oxford)
; 62(2): 872-885, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35792833
8.
Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries.
Rheumatology (Oxford)
; 62(2): 647-658, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35723604
9.
Second and third TNF inhibitors in European patients with axial spondyloarthritis: Effectiveness and impact of the reason for switching.
Rheumatology (Oxford)
; 2023 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738257
10.
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration.
Ann Rheum Dis
; 81(10): 1358-1366, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705376
11.
Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration.
Rheumatology (Oxford)
; 61(11): 4286-4296, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139178
12.
Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritis.
Clin Exp Rheumatol
; 40(7): 1393-1402, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34796837
13.
Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort study.
Rheumatology (Oxford)
; 60(8): 3656-3668, 2021 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33401297
14.
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis.
Rheumatology (Oxford)
; 60(8): 3635-3645, 2021 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33367900
15.
Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study.
Rheumatology (Oxford)
; 60(1): 140-146, 2021 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32591790
16.
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries.
Rheumatology (Oxford)
; 60(2): 820-828, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32810263
17.
Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis.
Rheumatology (Oxford)
; 59(9): 2455-2461, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31960053
18.
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA.
Rheumatology (Oxford)
; 59(7): 1640-1650, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31665497
19.
Gain-of-function CEBPE mutation causes noncanonical autoinflammatory inflammasomopathy.
J Allergy Clin Immunol
; 144(5): 1364-1376, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31201888
20.
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration.
Ann Rheum Dis
; 78(11): 1536-1544, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31431486